<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36355566</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Transthyretin attenuates TDP-43 proteinopathy by autophagy activation via ATF4 in FTLD-TDP.</ArticleTitle><Pagination><StartPage>2089</StartPage><EndPage>2106</EndPage><MedlinePgn>2089-2106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awac412</ELocationID><Abstract><AbstractText>TAR DNA-binding protein-43 (TDP-43) proteinopathies are accompanied by the pathological hallmark of cytoplasmic inclusions in the neurodegenerative diseases, including frontal temporal lobar degeneration-TDP and amyotrophic lateral sclerosis. We found that transthyretin accumulates with TDP-43 cytoplasmic inclusions in frontal temporal lobar degeneration-TDP human patients and transgenic mice, in which transthyretin exhibits dramatic expression decline in elderly mice. The upregulation of transthyretin expression was demonstrated to facilitate the clearance of cytoplasmic TDP-43 inclusions through autophagy, in which transthyretin induces autophagy upregulation via ATF4. Of interest, transthyretin upregulated ATF4 expression and promoted ATF4 nuclear import, presenting physical interaction. Neuronal expression of transthyretin in frontal temporal lobar degeneration-TDP mice restored autophagy function and facilitated early soluble TDP-43 aggregates for autophagosome targeting, ameliorating neuropathology and behavioural deficits. Thus, transthyretin conducted two-way regulations by either inducing autophagy activation or escorting TDP-43 aggregates targeted autophagosomes, suggesting that transthyretin is a potential modulator therapy for neurological disorders caused by TDP-43 proteinopathy.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Yuan-Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Lee-Way</ForeName><Initials>LW</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, UC Davis Medical Center, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liang-Chao</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Pei-Chuan</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Yen</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Kuen-Jer</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0002-2170-9735</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG010129</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG072972</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011228">Prealbumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497109">ATF4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>145891-90-3</RegistryNumber><NameOfSubstance UI="D051701">Activating Transcription Factor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011228" MajorTopicYN="N">Prealbumin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="Y">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051701" MajorTopicYN="N">Activating Transcription Factor 4</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATF4</Keyword><Keyword MajorTopicYN="N">FTLD</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">TTR</Keyword><Keyword MajorTopicYN="N">proteinopathy</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36355566</ArticleId><ArticleId IdType="pmc">PMC10411944</ArticleId><ArticleId IdType="doi">10.1093/brain/awac412</ArticleId><ArticleId IdType="pii">6820967</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Gustafson L, et al. . Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology. 1998;51:1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pubmed">9855500</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen-Plotkin AS, Lee VM, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol. 2010;6:211&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2892118</ArticleId><ArticleId IdType="pubmed">20234357</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248:612&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">11518004</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Wu LS, Chang HY, Shen CK. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem. 2008;105:797&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">18088371</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CE, Jin LW, Chu YP, Wei WY, Ho PC, Tsai KJ. TDP-43 proteinopathy impairs mRNP granule mediated postsynaptic translation and mRNA metabolism. Theranostics. 2021;11:330&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7681104</ArticleId><ArticleId IdType="pubmed">33391478</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Martinez-Lage M, Robinson J, et al. . Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol. 2009;66:180&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2774117</ArticleId><ArticleId IdType="pubmed">19204154</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem. 2008;283:13302&#x2013;13309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet. 2009;18:3353&#x2013;3364.</Citation><ArticleIdList><ArticleId IdType="pubmed">19515851</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Xu YF, Cook C, et al. . Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A. 2009;106:7607&#x2013;7612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671323</ArticleId><ArticleId IdType="pubmed">19383787</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheper W, Hoozemans JJ. The unfolded protein response in neurodegenerative diseases: A neuropathological perspective. Acta Neuropathol. 2015;130:315&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4541706</ArticleId><ArticleId IdType="pubmed">26210990</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature. 1999;397:271&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">9930704</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Raphael AR, LaDow ES, et al. . Therapeutic modulation of eIF2&#x3b1; phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet. 2014;46:152&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3934366</ArticleId><ArticleId IdType="pubmed">24336168</ArticleId></ArticleIdList></Reference><Reference><Citation>Matus S, Lopez E, Valenzuela V, Nassif M, Hetz C. Functional contribution of the transcription factor ATF4 to the pathogenesis of amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e66672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715499</ArticleId><ArticleId IdType="pubmed">23874395</ArticleId></ArticleIdList></Reference><Reference><Citation>Senft D, Ronai ZA. UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci. 2015;40:141&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4340752</ArticleId><ArticleId IdType="pubmed">25656104</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheper W, Nijholt DAT, Hoozemans JJM. The unfolded protein response and proteostasis in Alzheimer disease: Preferential activation of autophagy by endoplasmic reticulum stress. Autophagy. 2011;7:910&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3149694</ArticleId><ArticleId IdType="pubmed">21494086</ArticleId></ArticleIdList></Reference><Reference><Citation>Glick D, Barth S, Macleod KF. Autophagy: Cellular and molecular mechanisms. J Pathol. 2010;221:3&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2990190</ArticleId><ArticleId IdType="pubmed">20225336</ArticleId></ArticleIdList></Reference><Reference><Citation>Gi&#xe3;o T, Saavedra J, Cotrina E, et al. . Undiscovered roles for transthyretin: from a transporter protein to a new therapeutic target for Alzheimer's disease. Int J Mol Sci. 2020;21:2075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7139926</ArticleId><ArticleId IdType="pubmed">32197355</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum JN. Transthyretin and the transthyretin amyloidoses. In: Uversky VN and Fink AL, editors. Protein misfolding, aggregation, and conformational diseases: part B: Molecular mechanisms of conformational diseases. Springer, USA; 2007. p. 259&#x2013;283.</Citation></Reference><Reference><Citation>Saponaro F, Kim JH, Chiellini G. Transthyretin stabilization: an emerging strategy for the treatment of Alzheimer's disease? Int J Mol Sci. 2020;21:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7698513</ArticleId><ArticleId IdType="pubmed">33212973</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum JN, Ye Z, Reixach N, et al. . Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A. 2008;105:2681&#x2013;2686.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2268196</ArticleId><ArticleId IdType="pubmed">18272491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerridge C, Belyaev ND, Nalivaeva NN, Turner AJ. The A&#x3b2;-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain. J Neurochem. 2014;130:419&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">24528201</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira M, Saraiva MJ. Transthyretin: A multifaceted protein. Biomol Concepts. 2014;5:45&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">25372741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai KJ, Yang CH, Fang YH, et al. . Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U. J Exp Med. 2010;207:1661&#x2013;1673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916125</ArticleId><ArticleId IdType="pubmed">20660618</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Vance C, Nishimura AL, et al. . Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci. 2014;127:1263&#x2013;1278.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma S, Beermann ML, Boyce FM, Miller JB. Expression of FSHD-related DUX4-FL alters proteostasis and induces TDP-43 aggregation. Ann Clin Transl Neurol. 2015;2:151&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338956</ArticleId><ArticleId IdType="pubmed">25750920</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Song J, Huang H, Chen H, Qian K. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Stem Cell Res Ther. 2018;9:315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238404</ArticleId><ArticleId IdType="pubmed">30442180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. Control of memory formation through regulated expression of a CaMKII transgene. Science. 1996;274:1678&#x2013;1683.</Citation><ArticleIdList><ArticleId IdType="pubmed">8939850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CE, Chu YP, Tsai KJ. Structure-based analysis of protein cluster size for super-resolution microscopy in the nervous system. Biomedicines. 2022;10:295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8869149</ArticleId><ArticleId IdType="pubmed">35203503</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai KJ, Tsai YC, Shen CK. G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med. 2007;204:1273&#x2013;1280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118601</ArticleId><ArticleId IdType="pubmed">17517969</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahheydari H, Ragagnin A, Walker AK, et al. . Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum. Front Mol Neurosci. 2017;10:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423993</ArticleId><ArticleId IdType="pubmed">28539871</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabas I, Ron D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol. 2011;13:184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3107571</ArticleId><ArticleId IdType="pubmed">21364565</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Yamada M, Tanaka H, et al. . Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice. Neurobiol Dis. 2009;36:470&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">19733664</ArticleId></ArticleIdList></Reference><Reference><Citation>Luhr M, Torgersen ML, Szalai P, et al. . The kinase PERK and the transcription factor ATF4 play distinct and essential roles in autophagy resulting from tunicamycin-induced ER stress. J Biol Chem. 2019;294:8197&#x2013;8217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527152</ArticleId><ArticleId IdType="pubmed">30926605</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci. 2019;12:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibutani ST, Yoshimori T. A current perspective of autophagosome biogenesis. Cell Res. 2014;24:58&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3879706</ArticleId><ArticleId IdType="pubmed">24296784</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauterbach MA. Finding, defining and breaking the diffraction barrier in microscopy&#x2014;A historical perspective. Optical Nanoscopy. 2012;1:8.</Citation></Reference><Reference><Citation>Kedia S, Ramakrishna P, Netrakanti PR, et al. . Alteration in synaptic nanoscale organization dictates amyloidogenic processing in Alzheimer's disease. iScience. 2021;24:101924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7773964</ArticleId><ArticleId IdType="pubmed">33409475</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: A general repository for interaction datasets. Nucleic Acids Res. 2006;34:D535&#x2013;D539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1347471</ArticleId><ArticleId IdType="pubmed">16381927</ArticleId></ArticleIdList></Reference><Reference><Citation>Rzymski T, Milani M, Pike L, et al. . Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene. 2010;29:4424&#x2013;4435.</Citation><ArticleIdList><ArticleId IdType="pubmed">20514020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Sun Q, Zhao C, et al. . HDAC4 protects cells from ER stress induced apoptosis through interaction with ATF4. Cell Signal. 2014;26:556&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pubmed">24308964</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding WX, Ni HM, Gao W, et al. . Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol. 2007;171:513&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1934546</ArticleId><ArticleId IdType="pubmed">17620365</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IF, Guo BS, Liu YC, et al. . Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A. 2012;109:15024&#x2013;15029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3443184</ArticleId><ArticleId IdType="pubmed">22932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci. 2006;7:278&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3710114</ArticleId><ArticleId IdType="pubmed">16552414</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa R, Ferreira-da-Silva F, Saraiva MJ, Cardoso I. Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS ONE. 2008;3:e2899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2483353</ArticleId><ArticleId IdType="pubmed">18682830</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzman AL, Gregori L, Vitek MP, et al. . Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A. 1994;91:8368&#x2013;8372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44607</ArticleId><ArticleId IdType="pubmed">8078889</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Murphy RM. Kinetics of inhibition of beta-amyloid aggregation by transthyretin. Biochemistry. 2006;45:15702&#x2013;15709.</Citation><ArticleIdList><ArticleId IdType="pubmed">17176092</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Buxbaum JN. Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease? Mol Neurodegener. 2011;6:79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3267701</ArticleId><ArticleId IdType="pubmed">22112803</ArticleId></ArticleIdList></Reference><Reference><Citation>Iridoy MO, Zubiri I, Zelaya MV, et al. . Neuroanatomical quantitative proteomics reveals common pathogenic biological routes between amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Int J Mol Sci. 2018;20:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6337647</ArticleId><ArticleId IdType="pubmed">30577465</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H, An J, Darko S, et al. . Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve. 2010;42:104&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2975276</ArticleId><ArticleId IdType="pubmed">20583124</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Lehmensiek V, Mogel H, et al. . Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci Lett. 2010;468:23&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">19853641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H, Zhai W, Lu X, Wang G. The cross-links of endoplasmic reticulum stress, autophagy, and neurodegeneration in Parkinson's disease. Front Aging Neurosci. 2021;13:691881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8218021</ArticleId><ArticleId IdType="pubmed">34168552</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetz C, Saxena S. ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol. 2017;13:477&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">28731040</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Fragoza R, Klei L, et al. . An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders. Nat Genet. 2018;50:1032&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6314957</ArticleId><ArticleId IdType="pubmed">29892012</ArticleId></ArticleIdList></Reference><Reference><Citation>Rual JF, Venkatesan K, Hao T, et al. . Towards a proteome-scale map of the human protein-protein interaction network. Nature. 2005;437:1173&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">16189514</ArticleId></ArticleIdList></Reference><Reference><Citation>B'Chir W, Maurin AC, Carraro V, et al. . The eIF2&#x3b1;/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res. 2013;41:7683&#x2013;7699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763548</ArticleId><ArticleId IdType="pubmed">23804767</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira M, Gomes JR, Saraiva MJ. Transthyretin induces insulin-like growth factor I nuclear translocation regulating its levels in the hippocampus. Mol Neurobiol. 2015;51:1468&#x2013;1479.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4434863</ArticleId><ArticleId IdType="pubmed">25084758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wortel IMN, van der Meer LT, Kilberg MS, van Leeuwen FN. Surviving stress: modulation of ATF4-mediated stress responses in normal and malignant cells. Trends Endocrinol Metab. 2017;28:794&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5951684</ArticleId><ArticleId IdType="pubmed">28797581</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon E, Meyer G, Pickard L, et al. . GABA(B) receptors couple directly to the transcription factor ATF4. Mol Cell Neurosci. 2001;17:637&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">11312600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehring RB, Horikawa HPM, El Far O, et al. . The metabotropic GABAB receptor directly interacts with the activating transcription factor 4. J Biol Chem. 2000;275:35185&#x2013;35191.</Citation><ArticleIdList><ArticleId IdType="pubmed">10924501</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger TA, Yao TP. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J Neurosci. 2005;25:9544&#x2013;9553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725694</ArticleId><ArticleId IdType="pubmed">16221865</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira M, Leal SS, Gomes CM, Saraiva MJ. Evidence for synergistic action of transthyretin and IGF-I over the IGF-I receptor. Biochim Biophys Acta. 2016;1862:797&#x2013;804.</Citation><ArticleIdList><ArticleId IdType="pubmed">26804653</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>